PSTPIP2: A Potential Cancer Drug Target (G9050)

Target Name: PSTPIP2

NCBI ID: G9050

PSTPIP2

PSTPIP2: A Potential Cancer Drug Target

Post-Transcriptional Modification-Informed Polymorphism (PSTPIP2) is a non-coding RNA molecule that plays a crucial role in regulating gene expression in various organisms, including humans. PSTPIP2 is a protein that is composed of 219 amino acids and has been shown to have various functions in different cellular processes, including cell adhesion, migration, and invasion.

PSTPIP2 as a drug target

PSTPIP2 has been identified as a potential drug target in the field of cancer. Several studies have shown that PSTPIP2 can be downregulated in various types of cancer, including breast, lung, and ovarian cancer. This downregulation of PSTPIP2 has been associated with the development of cancer stem cells, which are cancer-promoting cells that can resist chemotherapy and radiation treatment.

One of the potential mechanisms by which PSTPIP2 contributes to cancer development is by regulating the activity of cell signaling pathways that promote the growth and survival of cancer cells. For example, PSTPIP2 has been shown to play a role in the regulation of the TGF-β pathway, which is a well-known signaling pathway that promotes the growth and survival of cancer cells.

Another potential mechanism by which PSTPIP2 contributes to cancer development is by regulating the activity of cell signaling pathways that promote the angiogenesis of cancer. Angiogenesis is the process by which new blood vessels are formed in the body, and it is a critical process for the growth and survival of cancer cells.

PSTPIP2 has been shown to play a role in the regulation of angiogenesis by the production of pro-angiogenic factors, such as VEGF. VEGF is a potent angiogenic factor that promotes the formation of new blood vessels, and it has been shown to contribute to the development of various types of cancer, including cancer.

In conclusion, PSTPIP2 is a non-coding RNA molecule that has been identified as a potential drug target in the field of cancer. Its functions in regulating cell signaling pathways and the regulation of angiogenesis have been well-studied, and its potential as a drug target is under investigation. Further research is needed to determine the exact mechanisms by which PSTPIP2 contributes to cancer development and the potential of PSTPIP2 as a drug.

Protein Name: Proline-serine-threonine Phosphatase Interacting Protein 2

Functions: Binds to F-actin. May be involved in regulation of the actin cytoskeleton (By similarity)

The "PSTPIP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PSTPIP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets